Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2025-03-04 Sale |
2025-03-04 4:43 pm |
Intellia Therapeutics Inc. | NTLA | Clark Eliana EVP, Chief Technical Officer |
679 | $8.99 | $6,104 | 141,083 (Direct) |
View |
| 2025-01-02 Sale |
2025-01-06 4:16 pm |
Intellia Therapeutics Inc. | NTLA | Clark Eliana EVP, Chief Technical Officer |
7,978 | $12.17 | $97,089 | 64,048 (Direct) |
View |
| 2024-07-01 Sale |
2024-07-03 1:15 pm |
Intellia Therapeutics Inc. | NTLA | Clark Eliana EVP, Chief Technical Officer |
405 | $22.93 | $9,287 | 71,470 (Direct) |
View |
| 2024-03-04 Sale |
2024-03-05 4:10 pm |
Intellia Therapeutics Inc. | NTLA | Clark Eliana EVP, Chief Technical Officer |
605 | $32.99 | $19,959 | 116,542 (Direct) |
View |
| 2024-01-03 Sale |
2024-01-05 4:44 pm |
Intellia Therapeutics Inc. | NTLA | Clark Eliana EVP, Chief Technical Officer |
4,608 | $29.5 | $135,954 | 40,845 (Direct) |
View |
| 2023-07-03 Sale |
2023-07-06 3:34 pm |
Intellia Therapeutics Inc. | NTLA | Clark Eliana EVP, Chief Technical Officer |
360 | $40.51 | $14,584 | 45,146 (Direct) |
View |
| 2023-06-20 Sale |
2023-06-22 5:52 pm |
Intellia Therapeutics Inc. | NTLA | Clark Eliana EVP, Chief Technical Officer |
5,000 | $45 | $225,000 | 102,896 (Direct) |
View |
| 2022-07-01 Sale |
2023-01-06 5:21 pm |
Intellia Therapeutics Inc. | NTLA | Clark Eliana EVP, Chief Technical Officer |
2,028 | $37.65 | $76,357 | 14,473 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-03-01 Option Award |
2025-03-04 4:43 pm |
N/A 2035-02-28 |
Intellia Therapeutics Inc. | NTLA | Clark Eliana EVP, Chief Technical Officer |
77,714 | $0 | 141,083 (Direct) |
View |
| 2024-03-01 Option Award |
2024-03-05 4:10 pm |
N/A 2034-02-28 |
Intellia Therapeutics Inc. | NTLA | Clark Eliana EVP, Chief Technical Officer |
76,302 | $0 | 116,542 (Direct) |
View |
| 2023-06-20 Exercise |
2023-06-22 5:52 pm |
N/A N/A |
Intellia Therapeutics Inc. | NTLA | Clark Eliana EVP, Chief Technical Officer |
5,000 | $12.27 | 102,896 (Direct) |
View |
| 2023-06-20 Exercise |
2023-06-22 5:52 pm |
N/A 2030-02-02 |
Intellia Therapeutics Inc. | NTLA | Clark Eliana EVP, Chief Technical Officer |
5,000 | $0 | 102,896 (Direct) |
View |
| 2023-03-01 Option Award |
2023-03-03 5:12 pm |
N/A 2033-02-28 |
Intellia Therapeutics Inc. | NTLA | Clark Eliana EVP, Chief Technical Officer |
65,347 | $0 | 79,820 (Direct) |
View |
| 2022-03-01 Option Award |
2022-03-07 7:19 pm |
N/A 2032-02-28 |
Intellia Therapeutics Inc. | NTLA | Clark Eliana EVP, Chief Technical Officer |
25,922 | $0 | 31,560 (Direct) |
View |
Ownership |
2022-03-07 7:15 pm |
N/A N/A |
Intellia Therapeutics Inc. | NTLA | Clark Eliana EVP, Chief Technical Officer |
0 | $0 | 99,888 (Direct) |
View |